Federal Register / Vol. 88, No. 221 / Friday, November 17, 2023 / Notices 80321 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors attending a meeting on 

campus or at an off-campus federal facility 

will be asked to show one form of 

identification (for example, a governmentissued photo ID, driver’s license, or passport) 

and to state the purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: http://

acd.od.nih.gov, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: November 13, 2023. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2023–25376 Filed 11–16–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Amended Notice 

of Meeting 

Notice is hereby given of a change in 

the meeting of the National Institute of 

Neurological Disorders and Stroke 

Special Emphasis Panel, November 17, 

2023, 10:00 a.m. to 04:00 p.m., National 

Institutes of Health, Neuroscience 

Center, 6001 Executive Boulevard, 

Rockville, MD 20852 which was 

published in the Federal Register on 

November 3, 2023, 88 FR 77102. 

This notice is being amended to 

change this one-day meeting from 

November 17, 2023, to November 27, 

2023. The meeting time remains the 

same. The meeting is closed to the 

public. 

Dated: November 13, 2023. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2023–25404 Filed 11–16–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Establishment of the Board of 

Scientific Counselors, Division of 

Translational Toxicology, National 

Institute of Environmental Health 

Sciences 

Pursuant to the Federal Advisory 

Committee Act, as amended (5 U.S.C. 

1001–1014), the Director, National 

Institutes of Health (NIH) announces the 

establishment of the Board of Scientific 

Counselors, Division of Translational 

Toxicology, National Institute of 

Environmental Health Sciences, as 

authorized by 42 U.S.C. 282(b)(16), 

section 402(b)(16) of the Public Health 

Service Act, as amended. 

The Director, NIH, has determined 

that the Board of Scientific Counselors, 

Division of Translational Toxicology, 

National Institute of Environmental 

Health Sciences is in the public interest 

in connection with the performance of 

duties imposed on NIH by law, and that 

these duties can best be performed 

through the advice and counsel of the 

committee. 

The committee will review and 

evaluate the intramural program and the 

work of tenured, tenure track, and staff 

scientists and physicians and shall also, 

as requested by the Director, NIH, 

undertake peer review of extramural 

funding applications as required by 

section 492 of the Public Health Service 

Act, as amended. 

Inquiries may be directed to Claire 

Harris, Director, Office of Federal 

Advisory Committee Policy, Office of 

the Director, National Institutes of 

Health, 6701 Democracy Boulevard, 

Suite 1000, Bethesda, Maryland 20892 

(Mail code 4875), Telephone (301) 496– 

2123, or Claire.Harris@nih.gov. 

Dated: November 13, 2023. 

Monica M. Bertagnolli, 

Director, National Institutes of Health. 

[FR Doc. 2023–25472 Filed 11–16–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Advancing 

Translational Sciences; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Advancing Translational Sciences Special 

Emphasis Panel; CTSA Collaborative and 

Innovative Acceleration Awards. 

Date: February 7, 2024. 

Time: 11:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, 6701 Democracy Boulevard, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: M. Lourdes Ponce, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review, National Center for Advancing 

Translational Sciences, National Institutes of 

Health, 6701 Democracy Boulevard, Room 

1068, Bethesda, MD 20892, (301) 435–0810, 

lourdes.ponce@nih.gov. 

Name of Committee: National Center for 

Advancing Translational Sciences Special 

Emphasis Panel; Understudied Proteins 

Associated with Rare Diseases (R03) Review. 

Date: February 29, 2024. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, 6701 Democracy Boulevard, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ming Yan, MD, Ph.D. 

Scientific Review Officer Scientific Review 

Branch Division of Extramural Activities 

National Center for Advancing Translational 

Sciences 6701 Democracy Boulevard, MSC 

4874 Bethesda, MD 20892 (301) 827–4312 

ming.yan@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.350, B—Cooperative 

Agreements; 93.859, Biomedical Research 

and Research Training, National Institutes of 

Health, HHS) 


khammond on DSKJM1Z7X2PROD with NOTICES